SIS
GSK icon

Susquehanna International Securities’s GSK GSK Stock Holding History

Susquehanna International Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40,000
Closed -$1.88M – 50
2020
Q3 		$1.88M Buy
+40,000
New +$2M 0.99% 21
2020
Q2 		– Sell
-40,000
Closed -$1.9M – 84
2020
Q1 		$1.9M Sell
40,000
-15,760
-28% -$841K 0.77% 31
2019
Q4 		$3.27M Sell
55,760
-39,120
-41% -$2.18M 1.24% 26
2019
Q3 		$5.06M Buy
94,880
+48,960
+107% +$2.52M 1.11% 26
2019
Q2 		$2.3M Buy
+45,920
New +$2.3M 0.74% 35

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Securities's GSK Position: Q1 2024 in Review

Susquehanna International Securities sold out of GSK (GSK) in Q1 2024, closing a stake of 20,308 shares — an estimated $753K sold.

Susquehanna International Securities first reported a position in GSK in Q4 2019 and held it in 3 quarters. The position peaked at $3.95M in Q4 2019. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Susquehanna International Securities reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Securities sold 20,308 GSK shares in Q1 2024, an estimated $753K.
  • Susquehanna International Securities first reported a position in GSK in Q4 2019 and held it in 3 quarters.
  • Susquehanna International Securities's GSK position peaked at $3.95M in Q4 2019.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Susquehanna International Securities's 13F filing for Q1 2024, filed 7 May 2024.